This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Thomas J. Gill III, MD; David E. Jenkins, Jr, MD

JAMA. 1984;252(2):258-260.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The article by Blumberg and associates describing the antigen that was ultimately found to be associated with infection by the hepatitis B virus (HBV)¹ presents a classic example of serendipity in scientific research and the fact that "chance favors the prepared mind." It also presents a fascinating insight into the nature of the scientific process and the way in which important discoveries are made.²

The work was careful, logical, and meticulous. It provided solid evidence for the presence of an antigenic system that was later identified as that of the HBV. The initial interpretation of the work was colored by a fortuitous association between the presence of the antigen and patients with leukemia. However, Blumberg and colleagues quickly grasped the true significance of their finding, ie, that the presence of the antigen was associated with blood transfusion and the subsequent development of hepatitis. Their observations became a new . . . [Full Text PDF of this Article]

Author Affiliations
From the Departments of Pathology (Dr Gill) and Pathology and Medicine (Dr Jenkins), University of Pittsburgh School of Medicine, and the Central Blood Bank of Pittsburgh (Dr Jenkins).

Footnotes
Reprint requests to University Health Center, Department of Pathology, Scaife Hall, Pittsburgh, PA 15261 (Dr Gill).

A commentary on Blumberg BS, Alter HJ, Visnich S: A 'new' antigen in leukemia sera. JAMA 1965;191:541-546.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?